Seattle Genetics (SGEN)
54.22
-2.33 -4.12%
NASDAQ
Jun 27, 11:48
Delayed 2m
USD
View All Key Stats
SGEN Key Stats
| Income Statement | |
| Revenue (TTM) | 416.12M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.27 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -179.62M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 89.13% |
| Profit Margin (Quarterly) | -54.97% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 7.738B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 18.42 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 12.82 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -78.13M |
| Return on Equity (TTM) | -27.61% |
View All SGEN News
SGEN News
-
WireHeadlineTime (ET)
-
Yahoo06/27 11:15
-
Yahoo06/27 08:00
-
Yahoo06/26 21:32
-
Yahoo06/26 16:57
-
Yahoo06/26 16:36
-
Yahoo06/26 16:10
-
Yahoo06/26 14:52
-
Yahoo06/26 13:13
-
MT Newswires06/26 12:55
-
Yahoo06/26 12:36
View All Events
SGEN Events
| Date | Type | Description |
|---|---|---|
| 05/19/2017 | Misc | Seattle Genetics Inc Annual General Meeting in 2016 |
| 04/27/2017 16:30 EDT | Misc | Seattle Genetics Inc First Quarter Earnings Conference Call in 2017 |
| 04/27/2017 | Earnings | Seattle Genetics Inc First Quarter Earnings in 2017 Release |
| 02/09/2017 16:30 EST | Misc | Seattle Genetics Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/09/2017 | Earnings | Seattle Genetics Inc Fourth Quarter Earnings in 2016 Release |
| 10/27/2016 16:30 EDT | Misc | Seattle Genetics Inc Third Quarter Earnings Conference Call in 2016 |
| 10/27/2016 | Earnings | Seattle Genetics Inc Third Quarter Earnings in 2016 Release |
| 07/26/2016 16:30 EDT | Misc | Seattle Genetics Inc Second Quarter Earnings Conference Call in 2016 |
| 07/26/2016 | Earnings | Seattle Genetics Inc Second Quarter Earnings in 2016 Release |
SGEN Fundamentals
Income Statement View Statement
SGEN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
SGEN One Page Reports
- One Page Report Download
SGEN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 54.22 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.seattlegenetics.com
- Investor Relations URL: http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-IRHome
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Seattle Genetics Inc is a development-stage biotech company. It develops monoclonal antibody-based therapies. Its lead product, Adcetris, has received approval for relapsed/refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma.
SGEN Comparables
EditSGEN Excel Add-In Codes
- Name: =YCI("SGEN","name")
- Description: =YCI("SGEN","description")
- Sector: =YCI("SGEN","sector")
- Industry: =YCI("SGEN","industry")
- Est. Current Fiscal Year End: =YCI("SGEN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other SGEN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SGEN Tweets Stocktwits
Advertisement
